Unravelling the Role of Gut and Oral Microbiota in the Pediatric Population with Type 1 Diabetes Mellitus DOI Open Access
Stefania Luppi, Luana Aldegheri, Eros Azzalini

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(19), С. 10611 - 10611

Опубликована: Окт. 2, 2024

Type 1 Diabetes Mellitus (T1DM) is a chronic autoimmune disease that results in the destruction of pancreatic β cells, leading to hyperglycaemia and need for lifelong insulin therapy. Although genetic predisposition environmental factors are considered key contributors T1DM, exact causes remain partially unclear. Recent evidence has focused on relationship between gut, oral cavity, immune regulation, systemic inflammation. In individuals with changes gut microbial composition commonly observed, indicating dysbiosis may contribute dysregulation. Gut can influence system through increased intestinal permeability, altered production short chain fatty acids (SCFAs), interactions mucosal system, potentially triggering response. Similarly, development inflammation thus progression T1DM. A comprehensive understanding these relationships essential identification biomarkers early diagnosis monitoring, as well therapies aimed at restoring balance. This review presents synthesis current research connection T1DM microbiome dysbiosis, focus microbiomes pediatric populations. It explores potential mechanisms by which contributes pathogenesis examines microbiome-based therapies, including probiotics, prebiotics, synbiotics, faecal microbiota transplantation (FMT). complex highlights longitudinal studies monitor over time, investigate causal specific species develop personalised medicine approaches.

Язык: Английский

From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes DOI Creative Commons

Lente Blok,

Nordin M.J. Hanssen,

Max Nieuwdorp

и другие.

Metabolites, Год журнала: 2025, Номер 15(2), С. 138 - 138

Опубликована: Фев. 19, 2025

Background: Type 1 diabetes (T1D) is a severe chronic T-cell mediated autoimmune disease that attacks the insulin-producing beta cells of pancreas. The multifactorial nature T1D involves both genetic and environmental components, with recent research focusing on gut microbiome as crucial factor in pathogenesis. its metabolites play an important role modulating immunity autoimmunity. In years, studies have revealed significant alterations taxonomic functional composition associated development islet autoimmunity T1D. These changes include reduced production short-chain fatty acids, altered bile acid tryptophan metabolism, increased intestinal permeability consequent perturbations host (auto)immune responses. Methods/Results: this review, we summarize discuss observational, mechanistic etiological investigating elucidating intricate microbes Moreover, highlight advances intervention targeting microbiota for prevention or treatment human Conclusions: A deeper understanding evolution before after onset microbial signals conditioning may provide us essential insights exploiting prognostic therapeutic tool.

Язык: Английский

Процитировано

1

The role of gut–islet axis in pancreatic islet function and glucose homeostasis DOI Creative Commons
Qi Chen,

Yuanyuan Gao,

Fangyu Li

и другие.

Diabetes Obesity and Metabolism, Год журнала: 2025, Номер unknown

Опубликована: Фев. 6, 2025

Abstract The gastrointestinal tract plays a vital role in the occurrence and treatment of metabolic diseases. Recent studies have convincingly demonstrated bidirectional axis communication between gut islets, enabling to influence glucose metabolism energy homeostasis animals strongly. ‘gut–islet axis’ is an essential endocrine signal that regulates islet function through dialogue intestinal microecology metabolism. discovery glucagon‐like peptide‐1 (GLP‐1), gastric inhibitory peptide (GIP) other hormones has initially set up bridge cells. However, factors remains largely unknown, such as microbiota integrity barrier. Although primarily resides affect function, they also extra‐intestinal organs by absorbing transferring metabolites derived from microorganisms. As result this transfer, islets may be continuously exposed gut‐derived components. Changes composition can damage barrier varying degrees, resulting increased permeability bacteria their derivatives. All these changes contribute severe disturbance critical pathways peripheral tissues organs. In review, we outlined different gut–islet signalling mechanisms associated with summarized latest progress complex molecules microbiota. addition, will discuss impact renin–angiotensin system (RAS) on various components regulate homeostasis. This work indicates therapeutic approaches aiming restore microbial homeostasis, probiotics faecal transplantation (FMT), shown great potential improving outcomes, enhancing patient prognosis slowing down disease progression. Future research should further uncover molecular links explore individualized strategies, which provide innovative perspective approach for diagnosis

Язык: Английский

Процитировано

0

Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders DOI Open Access
Emiliano Peña-Durán, Jesús Jonathan García-Galindo,

Luis D. López-Murillo

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(4), С. 1773 - 1773

Опубликована: Фев. 19, 2025

The human microbiota, a complex ecosystem of microorganisms, plays pivotal role in regulating host immunity and metabolism. This review investigates the interplay between microbiota inflammatory markers, emphasizing their impact on metabolic autoimmune disorders. Key biomarkers, such as C-reactive protein (CRP), interleukin-6 (IL-6), lipopolysaccharides (LPS), zonulin (ZO-1), netrin-1 (Ntn1), are discussed context intestinal barrier integrity chronic inflammation. Dysbiosis, characterized by alterations microbial composition function, directly modulates levels activity these exacerbating responses compromising epithelial barriers. disruption is further correlated with increased permeability inflammation, serving precursor to conditions like type 2 diabetes (T2D), obesity, non-alcoholic fatty liver disease. Additionally, this examines therapeutic strategies, including probiotics prebiotics, designed restore balance, mitigate enhance homeostasis. Emerging evidence positions microbiota-targeted interventions critical components advancement precision medicine, offering promising avenues for diagnosing treating

Язык: Английский

Процитировано

0

Autoimmunity and the microbiome DOI
Laura M. Cox, Vijay Kuchroo

Immunological Reviews, Год журнала: 2024, Номер 325(1), С. 4 - 8

Опубликована: Июль 9, 2024

Язык: Английский

Процитировано

2

Unravelling the Role of Gut and Oral Microbiota in the Pediatric Population with Type 1 Diabetes Mellitus DOI Open Access
Stefania Luppi, Luana Aldegheri, Eros Azzalini

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(19), С. 10611 - 10611

Опубликована: Окт. 2, 2024

Type 1 Diabetes Mellitus (T1DM) is a chronic autoimmune disease that results in the destruction of pancreatic β cells, leading to hyperglycaemia and need for lifelong insulin therapy. Although genetic predisposition environmental factors are considered key contributors T1DM, exact causes remain partially unclear. Recent evidence has focused on relationship between gut, oral cavity, immune regulation, systemic inflammation. In individuals with changes gut microbial composition commonly observed, indicating dysbiosis may contribute dysregulation. Gut can influence system through increased intestinal permeability, altered production short chain fatty acids (SCFAs), interactions mucosal system, potentially triggering response. Similarly, development inflammation thus progression T1DM. A comprehensive understanding these relationships essential identification biomarkers early diagnosis monitoring, as well therapies aimed at restoring balance. This review presents synthesis current research connection T1DM microbiome dysbiosis, focus microbiomes pediatric populations. It explores potential mechanisms by which contributes pathogenesis examines microbiome-based therapies, including probiotics, prebiotics, synbiotics, faecal microbiota transplantation (FMT). complex highlights longitudinal studies monitor over time, investigate causal specific species develop personalised medicine approaches.

Язык: Английский

Процитировано

0